Hueng-Sik Choi

Title: The Innovations of Hueng-Sik Choi

Introduction

Hueng-Sik Choi is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of methods and molecules that interact with retinoid X receptors and CAR receptors. With a total of three patents to his name, Choi's work has implications for therapeutic advancements.

Latest Patents

One of Hueng-Sik Choi's latest patents involves retinoid X receptor-interacting polypeptides and related methods. This patent discloses a method for determining whether a test protein can interact with a retinoid X receptor protein. The method includes providing a host cell that contains a reporter gene linked to a protein binding site, along with two fusion genes that express proteins capable of interacting with the test protein. The outcome of this interaction is measured by the expression of the reporter gene. Another significant patent focuses on CAR receptors, detailing purified DNA encoding these receptors and the recombinant proteins derived from them. This innovation is crucial for identifying CAR ligands and receptor binding sites, which can lead to the development of new therapeutics.

Career Highlights

Throughout his career, Hueng-Sik Choi has worked with reputable organizations, including The General Hospital Corporation. His research has contributed to advancements in understanding protein interactions and their potential therapeutic applications.

Collaborations

Choi has collaborated with notable colleagues such as David D Moore and Wongi Seol, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Hueng-Sik Choi's innovative work in the field of biochemistry has led to significant advancements in understanding protein interactions and their therapeutic potential. His contributions continue to influence research and development in this vital area of science.